Vasogen Inc.

Vasogen Inc. is focused on the development and commercialization of immune modulation therapies to advance the treatment of cardiovascular, autoimmune and related inflammatory diseases. These therapies utilize components derived from a sample of a patient's own blood that has been modified by physicochemical biological modifiers. Research has shown that returning modified cellular and extracellular blood components by intra-muscular injection down-regulates self-destructive immune system activity, resulting in lower levels of inflammation, less tissue damage, and a reduction in disease. The Company has immune modulation therapies in development for the treatment of cardiovascular and autoimmune disease, and for the prevention or amelioration of ischemia/reperfusion injury. Vasogen is also developing a process to prevent Graft-versus-Host Disease, a life threatening complication of bone marrow transplantation.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: